Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Cash & Equivalents (2016 - 2025)

Stemtech's Cash & Equivalents history spans 6 years, with the latest figure at $255416.0 for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 1.6% to $255416.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $255416.0, a 1.6% decrease, with the full-year FY2024 number at $255298.0, up 123.62% from a year prior.
  • Cash & Equivalents hit $255416.0 in Q3 2025 for Stemtech, down from $272450.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for STEK hit a ceiling of $1.6 million in Q3 2021 and a floor of $114166.0 in Q4 2023.
  • Historically, Cash & Equivalents has averaged $384703.2 across 5 years, with a median of $273999.0 in 2024.
  • Biggest five-year swings in Cash & Equivalents: surged 1372.4% in 2021 and later tumbled 92.3% in 2022.
  • Tracing STEK's Cash & Equivalents over 5 years: stood at $828206.0 in 2021, then tumbled by 84.0% to $132487.0 in 2022, then fell by 13.83% to $114166.0 in 2023, then surged by 123.62% to $255298.0 in 2024, then grew by 0.05% to $255416.0 in 2025.
  • Business Quant data shows Cash & Equivalents for STEK at $255416.0 in Q3 2025, $272450.0 in Q2 2025, and $305836.0 in Q1 2025.